menu search

SNTI / Senti Bio to Participate in Upcoming Conferences

Senti Bio to Participate in Upcoming Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases using its proprietary Gene Circuit platform, today announced its participation at the following investor and healthcare industry conferences: Read More
Posted: Sep 26 2023, 16:05
Author Name: GlobeNewsWire
Views: 111781

SNTI News  

Senti Bio to Participate in Upcoming Conferences

By GlobeNewsWire
September 26, 2023

Senti Bio to Participate in Upcoming Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company deve more_horizontal

Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
August 11, 2023

Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates

Senti Biosciences, Inc. (SNTI) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares more_horizontal


Search within

Pages Search Results: